LON:LID - LiDCO Group Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started GBX 6.50 0.00 (0.00 %) (As of 07/20/2018 12:24 PM ET)Previous CloseGBX 6.50Today's RangeGBX 6.30 - GBX 6.5052-Week RangeGBX 5.75 - GBX 10.25Volume401,967 shsAverage Volume183,119 shsMarket Capitalization£12.93 millionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileAnalyst RatingsInsider TradesHeadlinesChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company offers LiDCOplus, a computer-based platform monitor, which is used in the intensive care unit for real-time continuous display of hemodynamic parameters, such as cardiac output, oxygen delivery, and fluid-volume responsiveness; and LiDCOrapid, a cardiac output monitor for use in the operating theatre for fluid and drug management. It also provides LiDCOview, an easy-to-use graphical display of historical hemodynamic data that is used for research and education purposes; and LiDCOunity, a hemodynamic monitoring system to support clinical decision making. The company sells its products through direct sales and a network of a network of specialty critical care and anaesthesia distributors. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom. Receive LID News and Ratings via Email Sign-up to receive the latest news and ratings for LID and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Medical Appliances & Equipment Sub-IndustryN/A SectorMedical SymbolLON:LID CUSIPN/A Webwww.lidco.com Phone+44-20-77491500 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-25.80% Return on Equity-20.64% Return on Assets-17.53% Miscellaneous EmployeesN/A Outstanding Shares244,170,000Market Cap£12.93 LiDCO Group (LON:LID) Frequently Asked Questions What is LiDCO Group's stock symbol? LiDCO Group trades on the London Stock Exchange (LON) under the ticker symbol "LID." What price target have analysts set for LID? 1 equities research analysts have issued twelve-month price targets for LiDCO Group's shares. Their forecasts range from GBX 14 to GBX 14. On average, they expect LiDCO Group's share price to reach GBX 14 in the next twelve months. This suggests a possible upside of 115.4% from the stock's current price. View Analyst Ratings for LiDCO Group. What is the consensus analysts' recommendation for LiDCO Group? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LiDCO Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." Who are some of LiDCO Group's key competitors? Some companies that are related to LiDCO Group include Zecotek Photonics (ZMS), Theralase Technologies (TLT), Medaphor Group (MED), InspireMD (NSPR), Lucid (LCDX), Verisante Technology (VRS) and Deltex Medical Group (DEMG). Who are LiDCO Group's key executives? LiDCO Group's management team includes the folowing people: Mr. Matthew G. Sassone, CEO & DirectorMs. Jill McGregor, CFO, Company Sec. & DirectorDr. David M. Band, Co-Founder and Member of Clinical Advisory BoardMr. Shane Doorish, Head of North AmericaMs. Kerin Williams, Company Sec. Has LiDCO Group been receiving favorable news coverage? News articles about LID stock have trended somewhat positive this week, Accern reports. Accern identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. LiDCO Group earned a media sentiment score of 0.11 on Accern's scale. They also gave media headlines about the company an impact score of 45.39 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. How do I buy shares of LiDCO Group? Shares of LID and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is LiDCO Group's stock price today? One share of LID stock can currently be purchased for approximately GBX 6.50. How big of a company is LiDCO Group? LiDCO Group has a market capitalization of £12.93 million. How can I contact LiDCO Group? LiDCO Group's mailing address is 16 Orsman Road, LONDON, N1 5QJ, United Kingdom. The company can be reached via phone at +44-20-77491500. MarketBeat Community Rating for LiDCO Group (LON LID)Community Ranking: 1.8 out of 5 ()Outperform Votes: 121 (Vote Outperform)Underperform Votes: 219 (Vote Underperform)Total Votes: 340MarketBeat's community ratings are surveys of what our community members think about LiDCO Group and other stocks. Vote "Outperform" if you believe LID will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LID will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/20/2018 by MarketBeat.com StaffFeatured Article: Are Wall Street analysts' stock ratings worth following?